APA (7th ed.) Citation

Zeineddine, M., Al-Roughani, R., Farouk Ahmed, S., Khoury, S., El-Ayoubi, N., Al-Mahdawi, A., . . . Yamout, B. (2024). Safety and effectiveness of disease-modifying therapies after switching from natalizumab. Multiple Sclerosis Journal, 30(8), 1026. https://doi.org/10.1177/13524585241261565

Chicago Style (17th ed.) Citation

Zeineddine, Maya, et al. "Safety and Effectiveness of Disease-modifying Therapies After Switching from Natalizumab." Multiple Sclerosis Journal 30, no. 8 (2024): 1026. https://doi.org/10.1177/13524585241261565.

MLA (9th ed.) Citation

Zeineddine, Maya, et al. "Safety and Effectiveness of Disease-modifying Therapies After Switching from Natalizumab." Multiple Sclerosis Journal, vol. 30, no. 8, 2024, p. 1026, https://doi.org/10.1177/13524585241261565.